Realistic Lenalidomide Dose Adjustment Strategy for Transplant-Ineligible Elderly Patients with Relapsed/Refractory Multiple Myeloma: Japanese Real-World Experience

Lenalidomide is an immunomodulatory drug administered orally in the treatment of multiple myeloma. Some elderly patients require a reduced lenalidomide dose because of comorbidities and/or adverse events. This study investigated the actual dose of lenalidomide in elderly patients, finding that most...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Acta Haematol
Auteurs principaux: Nakaya, Aya, Fujita, Shinya, Satake, Atsushi, Nakanishi, Takahisa, Azuma, Yoshiko, Tsubokura, Yukie, Hotta, Masaaki, Yoshimura, Hideaki, Ishii, Kazuyoshi, Ito, Tomoki, Nomura, Shosaku
Format: Artigo
Langue:Inglês
Publié: S. Karger AG 2017
Sujets:
Original Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5872556/
https://ncbi.nlm.nih.gov/pubmed/28728162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000477792
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires